IRF3 and neoplasm: In contrast, acute activation of the cGAS-STING pathway often leads to anti-tumor immunity through TBK1-dependent activation of IRF3 and canonical NF-κB p65/p50 signaling, which mediate the transcription of type I IFN signaling53,60–62.